Natalie’s research is focused on advancing prostate cancer research to not only extend patient survival, but to provide targeted therapies tailored to patients on an individual basis. Her research program exploits the addiction of cancer cells to essential gene regulatory networks that are controlled by dominant, and predictable core sets of transcription factors.